PeerView Heart Lung & Blood CME/CNE/CPE Audio Podcast-logo

PeerView Heart Lung & Blood CME/CNE/CPE Audio Podcast

Education Podcasts >

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
More Information

Location:

United States

Description:

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care

1/18/2019
More
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care

Duration:00:41:00

Paul M. Ridker, MD, MPH, FACC, FAHA - Looking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis

1/14/2019
More
Looking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis

Duration:01:08:23

Edward B. Garon, MD, MS - Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice

1/2/2019
More
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice

Duration:01:05:44

Marc S. Sabatine, MD, MPH - Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?

1/2/2019
More
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?

Duration:01:17:02

Roy H. Decker, MD, PhD - The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal

12/28/2018
More
The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal

Duration:00:58:06

Lynette M. Sholl, MD - Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do

12/19/2018
More
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do

Duration:01:20:49

Amir T. Fathi, MD - The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care

12/17/2018
More
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care

Duration:00:42:10

Anjali Saqi, MD, MBA and Geoffrey R. Oxnard, MD - Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists

12/7/2018
More
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists

Duration:00:48:38

Marilyn K. Glassberg, MD - Examining the IPF Patient’s Journey to Diagnosis, Appropriate Therapy, and Overall Individualized Care

11/26/2018
More
Examining the IPF Patient’s Journey to Diagnosis, Appropriate Therapy, and Overall Individualized Care

Duration:00:41:33

Jonathan Corren, MD - A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies

11/21/2018
More
A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies

Duration:00:55:19

Loren del Mar Pena, MD, PhD - Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease

11/19/2018
More
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease

Duration:00:24:47

Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice

11/12/2018
More
Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice

Duration:00:38:11

Mario Castro, MD - An Expert Analysis of New Data for Uncontrolled Persistent Asthma Treatments: Clinical Updates From Paris

10/31/2018
More
An Expert Analysis of New Data for Uncontrolled Persistent Asthma Treatments: Clinical Updates From Paris

Duration:00:40:37

Nathan H. Fowler, MD - Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL

10/17/2018
More
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL

Duration:01:16:14

Kevin R. Flaherty, MD, MS - Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances

10/8/2018
More
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances

Duration:00:19:34

Javed Butler, MD, MPH - Examining the Role of Family Physicians in the Early Recognition and Management of Chronic Heart Failure

9/28/2018
More
Examining the Role of Family Physicians in the Early Recognition and Management of Chronic Heart Failure

Duration:00:44:23

Luca Richeldi, MD, PhD - Improving Care in ILD: Accurate Interpretation of HRCT and Advancing Therapies for Treatment

8/29/2018
More
Improving Care in ILD: Accurate Interpretation of HRCT and Advancing Therapies for Treatment

Duration:00:18:39

Kristin B. Highland, MD, MSCR - Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy

8/10/2018
More
Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy

Duration:01:01:00

Nick H. Kim, MD - Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

8/8/2018
More
Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

Duration:00:51:42

Lisa H. Lancaster, MD - Updates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment

8/6/2018
More
Updates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment

Duration:01:01:03